Showing results (241-250 of 356) with videos related to

Sort By:
Pageof 36
The International Journal of Eating Disorders|January 1, 1994
Excessive physical activity in dieting disorder patients: proposals for a supervised exercise programP J Beumont, B Arthur, J D Russell, et al.
Work (Reading, Mass.)|December 10, 2019
Piloting an empirical approach to link the international classification of functioning, disability, and health to job demand classificationChih-Ying Li, Paul B Arthur, Ickpyo Hong, et al.
Arzneimittel-Forschung|January 1, 1976
Synthetic analgesics: N-(1-[2-arylethyl]-4-substituted 4-piperidinyl) N-arylalkanamidesP G Van Daele, M F De Bruyn, J M Boey, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 14, 2025
CellEKT: A Chemical Proteomics Workflow to Profile Cellular Target Engagement of Kinase Inhibitors - A Step-by-Step GuideBerend Gagestein, Joel Rüegger, Antonius P A Janssen, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Intranasal pirodavir (R77,975) treatment of rhinovirus coldsF G Hayden, G J Hipskind, D H Woerner, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|July 6, 2012
Regeneration of hamstring tendons after anterior cruciate ligament reconstructionRob P A Janssen, Maria J F van der Velden, Huub L M Pasmans, et al.
European Journal of Pharmacology|January 2, 1989
Nebivolol is devoid of intrinsic sympathomimetic activityW J Janssens, A Van de Water, R Xhonneux, et al.
Journal of Experimental Orthopaedics|March 8, 2024
Anterolateral augmentation procedures during anterior cruciate ligament reconstructions in skeletally immature patients: Scoping review of surgical techniques and outcomesMartijn Dietvorst, Stéphanie Verhagen, Marieke C van der Steen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivoJ Van Wauwe, G Van Nyen, M C Coene, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1975
Unusual mechanism of hypotensive activity exerted by erytrho-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET-a1-4-piperidyl)-2-benzimidazolinone (R 28935)D Wellens, A De Wilde, A van Bogaert, et al.
Pageof 36